VIRIOS THERAPEUTICS INC (VIRI)

US92829J1043 - Common Stock

0.4558  +0.03 (+7.2%)

After market: 0.44 -0.02 (-3.47%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
5.45M12.32M15.64M10.01M2.18M
Research and Development
1.73M8.07M10.80M190.00K840.00K
Selling, General, and Administrative Expenses
3.72M4.25M4.85M9.81M1.34M
Operating Income
-5.45M-12.32M-15.64M-10.01M-2.18M
Interest Income/Expense
150.90K70.00K-320.00K-380.00K-300.00K
Other Income/Expense
N/AN/AN/A40.00K0.00
Income Before Taxes
-5.30M-12.25M-15.96M-10.35M-2.47M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-5.30M-12.25M-15.96M-10.35M-2.47M
 
Per Share Data
EPS Diluted Total Ops
-0.28-1.11-1.92-1.25-0.32
Non GAAP EPS
-0.28-1.31N/AN/AN/A
 
Statistics

All data in USD

Charts